Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
In this first of a two-part podcast on Helicobacter pylori, Drs Brian Lacy and William Chey discuss the prevalence of H pylori infection and how to best diagnose the condition.
In this first of a two-part podcast on Helicobacter pylori, Drs Brian Lacy and William Chey discuss the prevalence of H pylori infection and how to best diagnose the condition.
In part 2 of their podcast on Helicobacter pylori, Drs William Chey and Brian Lacy talk about the risks of untreated disease and the various types of treatment available.
In part 2 of their podcast on Helicobacter pylori, Drs William Chey and Brian Lacy talk about the risks of untreated disease and the various types of treatment available.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new update from the US Multi-Society Task Force on Colorectal Cancer revises and refines recommendations for optimizing bowel preparation in colonoscopy.
A new update from the US Multi-Society Task Force on Colorectal Cancer revises and refines recommendations for optimizing bowel preparation in colonoscopy.
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The TEMPO trial enrolled 40,000 adults aged 50–74 years and randomly assigned them to one of eight groups, testing combinations of a planning tool and deadline prompts of varying lengths.
The TEMPO trial enrolled 40,000 adults aged 50–74 years and randomly assigned them to one of eight groups, testing combinations of a planning tool and deadline prompts of varying lengths.
Do you know the dietary factors contributed the most to deaths from colorectal cancer in the G20 nations during 2021? Our quick quiz will answer that question!
Do you know the dietary factors contributed the most to deaths from colorectal cancer in the G20 nations during 2021? Our quick quiz will answer that question!
What comordid conditions put patients at risk of developing metabolic-dysfunction associated liver disease or steatohepatitis? Test your knowledge with our quick quiz!
What comordid conditions put patients at risk of developing metabolic-dysfunction associated liver disease or steatohepatitis? Test your knowledge with our quick quiz!
In this first of a two-part podcast on Helicobacter pylori, Drs Brian Lacy and William Chey discuss the prevalence of H pylori infection and how to best diagnose the condition.
In this first of a two-part podcast on Helicobacter pylori, Drs Brian Lacy and William Chey discuss the prevalence of H pylori infection and how to best diagnose the condition.
In part 2 of their podcast on Helicobacter pylori, Drs William Chey and Brian Lacy talk about the risks of untreated disease and the various types of treatment available.
In part 2 of their podcast on Helicobacter pylori, Drs William Chey and Brian Lacy talk about the risks of untreated disease and the various types of treatment available.
Discover the importance of acid suppression in H. pylori treatment with hosts Dr Michael Vaezi, professor of medicine at Vanderbilt University Medical Center and Dr David Peura, professor emeritus at the University of Virginia School of...
Discover the importance of acid suppression in H. pylori treatment with hosts Dr Michael Vaezi, professor of medicine at Vanderbilt University Medical Center and Dr David Peura, professor emeritus at the University of Virginia School of...
Dr Laurie Keefer joins Dr Brian Lacy to discuss brain-gut behavioral therapies, including hypnotherapy, and how they can help patients effectively cope with the chronic symptoms of digestive disorders as well as depression and anxiety.
Dr Laurie Keefer joins Dr Brian Lacy to discuss brain-gut behavioral therapies, including hypnotherapy, and how they can help patients effectively cope with the chronic symptoms of digestive disorders as well as depression and anxiety.
Dr Dacre Knight provides insights into hypermobility syndromes and their relationships to disorders of gut-brain interaction and gastrointestinal symptoms in the latest Gut Check, hosted by Dr Brian Lacy.
Dr Dacre Knight provides insights into hypermobility syndromes and their relationships to disorders of gut-brain interaction and gastrointestinal symptoms in the latest Gut Check, hosted by Dr Brian Lacy.
Host Brian Lacy, MD, is joined by Dr Michael Wallace to discuss the present and future applications of artificial intelligence in the practice of gastroenterology.
Host Brian Lacy, MD, is joined by Dr Michael Wallace to discuss the present and future applications of artificial intelligence in the practice of gastroenterology.
Dr Brian Lacy hosts Dr Carl Crawford of Weill Cornell to provide a comprehensive of the causes, risks, and treatment of Clostridioides difficile infection.
Dr Brian Lacy hosts Dr Carl Crawford of Weill Cornell to provide a comprehensive of the causes, risks, and treatment of Clostridioides difficile infection.
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Host Brian Lacy, MD, talks with Dr Rena Yadlapati about determining which patients may need antireflux surgery, types of surgical approaches, and possible complications.
Host Brian Lacy, MD, talks with Dr Rena Yadlapati about determining which patients may need antireflux surgery, types of surgical approaches, and possible complications.
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.
In this podcast, Drs Alan Bonder and Robert Gish discuss the need for universal screening for hepatitis D, the types of screening tests that should be used, and treatment options.
In this podcast, Drs Alan Bonder and Robert Gish discuss the need for universal screening for hepatitis D, the types of screening tests that should be used, and treatment options.
Dr Brian Lacy brings Dr Douglas Drossman back to Gut Check for a follow-up podcast on disorders of gut-brain interaction, to review the use of neuromodulators in treatment.
Dr Brian Lacy brings Dr Douglas Drossman back to Gut Check for a follow-up podcast on disorders of gut-brain interaction, to review the use of neuromodulators in treatment.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting metabolic dysfunction-associated steatotic liver disease.
A new update from the US Multi-Society Task Force on Colorectal Cancer revises and refines recommendations for optimizing bowel preparation in colonoscopy.
A new update from the US Multi-Society Task Force on Colorectal Cancer revises and refines recommendations for optimizing bowel preparation in colonoscopy.
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
For practicing gastroenterologists, these results highlight the importance of proactive risk assessment and coordinated care strategies in MASLD populations, beyond liver-specific endpoints.
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The study analyzed data from the Research Patient Data Registry between 2000 and 2023, focusing on patients aged 40 and older with a baseline FIB-4 score of 1.3 or higher.
The TEMPO trial enrolled 40,000 adults aged 50–74 years and randomly assigned them to one of eight groups, testing combinations of a planning tool and deadline prompts of varying lengths.
The TEMPO trial enrolled 40,000 adults aged 50–74 years and randomly assigned them to one of eight groups, testing combinations of a planning tool and deadline prompts of varying lengths.
